Keith Wayne Ward - Aug 25, 2023 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault
Stock symbol
SKYE
Transactions as of
Aug 25, 2023
Transactions value $
$0
Form type
4
Date filed
8/29/2023, 06:17 PM
Previous filing
Jan 9, 2023
Next filing
Nov 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Stock Option (Right to Buy) Award $0 +1.47M $0.00 1.47M Aug 25, 2023 Common Stock 1.47M $0.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant shall be exercisable for a price of $0.014 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023.